Prof. Schmid share his insight about his session topic introduced in this year's St. Gallen international conference.

Video: https://congressreport.eu/scientific-contents/interview:role-cancer-immunotherapy-treatment-patients-early-triple-negative-breast-cancer

Prof. Cardoso, this years ESO Umberto Veronesi memorial award recipient in her memorial lecture talked about the de-escalation of early breast cancer therapy, following Umberto Veronesi footsteps. In the second part of the interview,  Prof. Cardoso shares her opinion on HER2 guideline.

Video: https://congressreport.eu/scientific-contents/interview:de-escalation-early-breast-cancer-therapy-umberto-veronesis-legacy

Prof.  Federico Cappuzzo, Director of Medical Oncology in National Cancer Institute from Italy summarize the current state of frontline immunotherapy options in the treatment of NSCLC both in early stage and in metastatic advanced disease.

Video: https://congressreport.eu/scientific-contents/interview:current-state-frontline-immunotherapy-options-treatment-nsclc

Jeanny B. Aragon-Ching, MD, FACP make a brief summary about metastatic RCC first line trials. 

Video: https://congressreport.eu/scientific-contents/interview:balancing-efficacy-and-quality-life-measurements-among-metastatic-renal-cell-carcinoma-studies

Prof. Paolo Corradini speaks about the advance of CAR T-cell therapies and T-cell engaging antibodies.

Video: https://congressreport.eu/scientific-contents/interview:treatment-hematological-malignancies-2021

Prof. Giuseppe Saglio speaks about the latest news came out from the EHA meeting in the field of CML treatment.

Video: https://congressreport.eu/scientific-contents/interview:novelties-treatment-chronic-myeloid-leukemia